Ascend
Rockville, MD, United States ascend-adv.com
From their website, Nov 2026
Work here? Claim this listing
- GMP
About
Ascend is a gene-to-GMP development partner supporting advanced therapy developers from research through commercialization. It serves customers in the US and Europe with work on gene therapies, immunotherapies, oncolytics, and vaccines from sites in Rockville, Alachua, and Munich.
Services
Chemistry, manufacturing & controls (CMC)
Provides CMC support for advanced therapy programs.
Process design
Supports process design for biomanufacturing development programs.
Process feasibility
Evaluates process feasibility for client programs.
Upstream and downstream process development
Develops upstream and downstream processes for advanced therapy products.
Assay development and qualification
Develops and qualifies assays for product and process support.
Assays & in vitro testing
Master and working cell & virus banks
Creates master and working cell and virus banks.
Scale-up and engineering runs
Performs scale-up and engineering runs to move processes toward manufacturing.
GMP bulk drug substance
Manufactures GMP bulk drug substance.
CDMO: development & manufacturing
GMP aseptic fill/finish
Performs GMP aseptic fill and finish for drug product.
CDMO: development & manufacturing
Analytical lot release testing
Carries out analytical lot release testing.
Assays & in vitro testing
ICH stability testing
Performs ICH stability testing for product support.
Assays & in vitro testing
Regulatory guidance & filing
Provides regulatory guidance and filing support.
Platform innovation for AAV processes
Uses side-by-side platform comparisons and DoE to optimize AAV processes.
Gene therapy formulation
Performs high-throughput and focused formulation screening for gene therapy products, especially AAV.
Assays & in vitro testing
Scalable manufacturing
Scales processes from small volumes to larger bioreactors and supports downstream workflows, including fill/finish.
CDMO: development & manufacturing
Process development
Optimizes process conditions for AAV vector manufacturing, oncolytics, immunotherapies, and vaccines.
Aseptic fill-finish
Provides aseptic filling for viral vectors, gene therapies, oncolytics, vaccines, and other liquid biologics.
CDMO: development & manufacturing
Analytics & GMP QC testing
Offers characterization and release testing, including GMP QC testing for impurities, titer, potency, and related attributes.
Assays & in vitro testing
Viral vector long-read NGS
Uses Oxford Nanopore long-read sequencing to characterize viral vectors and detect impurities.
Potency assay services
Develops, qualifies, and validates mechanism-driven potency assays for gene therapies and ATMPs.
Assays & in vitro testing
EpyQ® AAV Production System
Provides a two-plasmid AAV production system for manufacturing support.
Master and working cell and virus banks
Creates master and working cell and virus banks for development and manufacturing programs.
Scalable manufacturing process development
Develops scalable manufacturing processes from small scale to larger bioreactors.
CDMO: development & manufacturing
- Turnaround
- 2-day turnaround
- What to send
- As little as ~5E9 vg for AAV · Minimal sample requirements · Low volume
Capabilities
- Assays and studies
- AAV · Fill-finish · Process development · NGS · Bioreactors · Lentivirus · ELISA · Cell therapy · Stability studies · ddPCR · Automated immunoassay · Dynamic light scattering
16 more
SEC · Full/empty methods · Capsid concentration · In vitro cell-based relative potency assays · Vector genome concentration · Infectious titre · Residual DNA testing · Subvisible particles · Endotoxin · NGS impurity characterization · Potency assays · VG/mL · %full capsid · Encapsidated genome length (NGS) · Particle aggregation · Visible particles - Scale and capacity
- 2L to 500L · 0.5L to 500L · 10 L scale · Up to 3000 vials per batch · 200 to 3,000 vials per lot · Up to 10,000 vials per lot · 57500 sqft GMP manufacturing facility in Alachua, Florida · 57000 sqft GMP Quality Control facility in Munich, Germany · 72000 sqft GMP manufacturing & testing facility in Rockville, Maryland · Three key locations · In-house fill/finish in two of its United States locations
- Therapeutic areas
- Gene therapy · Cell and gene therapy · Advanced therapies · CNS-directed gene therapies · Immunotherapies · Vaccines
Instruments and platforms
- Flexicon FPC50W
- Oxford Nanopore
- Stirred-tank bioreactors
- Orbital shaking bioreactors
- Rocking bioreactors
- Long-read NGS
- Droplet digital PCR (ddPCR)
- Automated immunoassay
- Dynamic light scattering
- SEC
Modalities and species
- Modalities
- Viral vector · Cell therapy · Vaccine · Plasmid DNA
- Species and models
- HEK293 cell line · Oxford Nanopore
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO 9001Self-reported
Scope: quality management system
GMPSelf-reported
Company
- Type
- CRDMO
Locations
- Address
- 9800 Medical Center Drive • Building D Rockville, MD 20850 USA
- Sites
- Rockville, USA · Alachua, USA · Munich, Germany
- Serves
- United States, Europe, global
Similar labs
Work here? Claim this listing